全文获取类型
收费全文 | 5064篇 |
免费 | 268篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 164篇 |
妇产科学 | 166篇 |
基础医学 | 813篇 |
口腔科学 | 76篇 |
临床医学 | 420篇 |
内科学 | 862篇 |
皮肤病学 | 96篇 |
神经病学 | 545篇 |
特种医学 | 155篇 |
外科学 | 389篇 |
综合类 | 59篇 |
预防医学 | 480篇 |
眼科学 | 361篇 |
药学 | 402篇 |
中国医学 | 8篇 |
肿瘤学 | 328篇 |
出版年
2023年 | 19篇 |
2022年 | 58篇 |
2021年 | 81篇 |
2020年 | 45篇 |
2019年 | 70篇 |
2018年 | 94篇 |
2017年 | 53篇 |
2016年 | 108篇 |
2015年 | 122篇 |
2014年 | 149篇 |
2013年 | 196篇 |
2012年 | 324篇 |
2011年 | 394篇 |
2010年 | 194篇 |
2009年 | 187篇 |
2008年 | 347篇 |
2007年 | 316篇 |
2006年 | 339篇 |
2005年 | 337篇 |
2004年 | 297篇 |
2003年 | 260篇 |
2002年 | 290篇 |
2001年 | 57篇 |
2000年 | 36篇 |
1999年 | 68篇 |
1998年 | 91篇 |
1997年 | 78篇 |
1996年 | 57篇 |
1995年 | 48篇 |
1994年 | 45篇 |
1993年 | 42篇 |
1992年 | 35篇 |
1991年 | 24篇 |
1990年 | 18篇 |
1989年 | 14篇 |
1988年 | 35篇 |
1987年 | 19篇 |
1986年 | 22篇 |
1985年 | 24篇 |
1984年 | 19篇 |
1983年 | 19篇 |
1982年 | 17篇 |
1981年 | 15篇 |
1980年 | 18篇 |
1979年 | 14篇 |
1978年 | 15篇 |
1977年 | 14篇 |
1974年 | 14篇 |
1964年 | 13篇 |
1962年 | 13篇 |
排序方式: 共有5342条查询结果,搜索用时 15 毫秒
91.
Pulsatile hypothalamic release of GnRH tightly controls reproduction by activating a specific cell membrane receptor (GnRHR) on the surface of pituitary gonadotrophs to stimulate luteinizing hormone and follicle-stimulating hormone secretion. During the last 10 years, 21 loss-of-function GNRHR mutations have been identified in patients with idiopathic hypogonadotropic hypogonadism. Although most patients with hypogonadotropic hypogonadism can be treated by delivery of exogenous pulsatile GnRH, in several cases, patients with GNRHR mutations fail to respond efficiently to GnRH treatment. The impact of each mutation on GnRHR function has been studied extensively in vitro, but correlation with clinical phenotype is not always evident. By combining recent advances into the molecular mechanisms controlling ligand binding and receptor activation with data accumulated from clinical studies, this review summarizes the overall structure-function relationships of the human GnRH receptor, with an emphasis on the impact of naturally occurring mutations. Furthermore, given that it was recently demonstrated that pharmacological chaperones can rescue altered receptor function in vitro, potential therapeutic approaches are also discussed. 相似文献
92.
93.
94.
Stark S Schuller A Sifringer M Gerstner B Brehmer F Weber S Altmann R Obladen M Buhrer C Felderhoff-Mueser U 《Neurotoxicity research》2008,13(3-4):197-207
Recent evidence suggests oxygen as a powerful trigger for cell death in the immature white matter, leading to periventricular leukomalacia (PVL) as a cause of adverse neurological outcome in survivors of preterm birth. This oligodendrocyte (OL) death is associated with oxidative stress, upregulation of apoptotic signaling factors (i.e., Fas, caspase-3) and decreased amounts of neurotrophins. In search of neuroprotective strategies we investigated whether the polysulfonated urea derivative suramin, recently identified as a potent inhibitor of Fas signaling, affords neuroprotection in an in vitro model of hyperoxia-induced injury to immature oligodendrocytes. Immature OLs (OLN-93) were subjected to 80% hyperoxia (48 h) in the presence or absence of suramin (0, 30, 60, 120 microM). Cell death was assessed by flow cytometry (Annexin V, caspase-3 activity assay) and immunohistochemistry for activated caspase-3. Immunoblotting for the death receptor Fas, cleaved caspase-8 and the phosphorylated isoform of the serine-threonin kinase Akt (pAkt) was performed. Suramin lead to OL apoptosis and potentiated hyperoxia-induced injury in a dose-dependent manner. Immunoblotting revealed increased Fas and caspase-8 expression by suramin treatment. This effect was significantly enhanced when suramin was combined with hyperoxia. Furthermore, pAkt levels decreased following suramin exposure, indicating interference with neurotrophin-dependent growth factor signaling. These data indicate that suramin causes apoptotic cell death and aggravates hyperoxia-induced cell death in immature OLs. Its mechanism of action includes an increase of previously described hyperoxia-induced expression of pro-apoptotic factors and deprivation of growth factor dependent signaling components. 相似文献
95.
Electronic assessment of peri‐implant mucosal esthetics around three implant–abutment configurations: a randomized clinical trial 下载免费PDF全文
96.
Anke Augspach Joachim H. List Philipp Wolf Heike Bielek Carsten Schwan Ursula Els?sser-Beile Klaus Aktories Gudula Schmidt 《Toxins》2013,5(11):2241-2257
Prostate cancer is the most common malignancy, accounting for about 25% of all incident cases among men in industrialized countries. The human androgen-dependent prostate cancer cell line LNCaP, which is derived from a metastatic lesion of human prostatic adenocarcinoma, is frequently used to study prostate cancer associated signaling pathways in vitro. Recently it was described that Rho GTPase activation in these cells leads to apoptotic responses. We used the bacterial toxins CNFy and CNF1, which specifically and directly activate Rho GTPases by deamidation of a single glutamine. We asked whether these Rho activators could induce apoptosis in LNCaP cells. Our results indicate that RhoA activation, induced by CNFy, does lead to intrinsic apoptosis of the cells. Analysis of the underlying signaling pathway reveals that apoptosis induction requires the activity of Rho kinase (ROCK) and myosin activation, an apoptotic pathway previously identified in cancer stem cells. 相似文献
97.
98.
99.
Parasitology Research - In Europe, up to 90% of isolated Trichomonas vaginalis strains are naturally infected with Mycoplasma hominis, a facultative pathogen of the human genital tract. The... 相似文献
100.
Belete A Desimmie Michael Humbert Eveline Lescrinier Jelle Hendrix Sofie Vets Rik Gijsbers Ruth M Ruprecht Ursula Dietrich Zeger Debyser Frauke Christ 《Molecular therapy》2012,20(11):2064-2075
The interaction between the human immunodeficiency virus (HIV) integrase (IN) and its cellular cofactor lens epithelium-derived growth factor (LEDGF/p75) is crucial for HIV replication. While recently discovered LEDGINs inhibit HIV-1 replication by occupying the LEDGF/p75 pocket in IN, it remained to be demonstrated whether LEDGF/p75 by itself can be targeted. By phage display we identified cyclic peptides (CPs) as the first LEDGF/p75 ligands that inhibit the LEDGF/p75–IN interaction. The CPs inhibit HIV replication in different cell lines without overt toxicity. In accord with the role of LEDGF/p75 in HIV integration and its inhibition by LEDGINs, CP64, and CP65 block HIV replication primarily by inhibiting the integration step. The CPs retained activity against HIV strains resistant to raltegravir or LEDGINs. Saturation transfer difference (STD) NMR showed residues in CP64 that strongly interact with LEDGF/p75 but not with HIV IN. Mutational analysis identified tryptophan as an important residue responsible for the activity of the peptides. Serial passaging of virus in the presence of CPs did not yield resistant strains. Our work provides proof-of-concept for direct targeting of LEDGF/p75 as novel therapeutic strategy and the CPs thereby serve as scaffold for future development of new HIV therapeutics. 相似文献